MESSAGE FROM OUR CEO
Dear Employees and Investors,
We are pleased to present our 2023-2024 Corporate Responsibility Report to you and to the public. This report builds on our prior reports and demonstrates our commitment to the values embodied in our mission.
At Medpace, our mission is to accelerate the global development of safe and effective medical therapeutics. We pursue our mission through responsibly managing our company and promoting an environment our most valuable assets – our people – will thrive. This requires our sensitivity to the needs of our employees, our support partners and vendors, the patients we care for, and the communities in which we operate.
Our view of corporate responsibility revolves around prioritizing ethical behavior in all we do, from our approach to executing clinical trials to our interactions with our sponsors and investors to the way we interact with the world around us. We have taken a comprehensive approach to corporate responsibility in not only doing what is expected or required of us as a corporate citizen under the laws and regulations with which we must comply, but also looking beyond the mere requirements and assessing how best to advance our mission. That is an important part of why our employees have chosen to work for us and why our investors have capitalized us. Our success is tied to our mission, and our mission is enhanced by operating in an honest, ethical, and conscientious manner.
Regards,
August J. Troendle